Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Predictors and timing of amputations in military lower extremity trauma with arterial injury.

Kauvar DS, Thomas SB, Schechtman DW, Walters TJ.

J Trauma Acute Care Surg. 2019 Jul;87(1S Suppl 1):S172-S177. doi: 10.1097/TA.0000000000002185.

PMID:
31246923
2.

Predictors and Timing of Amputations in Military Lower Extremity Trauma With Arterial Injury.

Thomas SB, Schechtman DW, Walters TJ, Kauvar DS.

J Trauma Acute Care Surg. 2019 Jan 10. doi: 10.1097/TA.0000000000002185. [Epub ahead of print]

PMID:
30633099
3.

Exploring Morphine-Triggered PKC-Targets and Their Interaction with Signaling Pathways Leading to Pain via TrkA.

Pena DA, Duarte ML, Pramio DT, Devi LA, Schechtman D.

Proteomes. 2018 Oct 6;6(4). pii: E39. doi: 10.3390/proteomes6040039. Review.

4.

Generating Conformation-Specific Polyclonal and Monoclonal Anti-Protein Kinase C Antibodies and Anti-Active State Specific PKC Antibodies.

Pena DA, Pacheco DMV, Oliveira PSL, Alves MJM, Schechtman D.

Curr Protoc Chem Biol. 2018 Jun;10(2):e42. doi: 10.1002/cpch.42. Epub 2018 Jun 12.

PMID:
29927112
5.

Despite Trauma Center Closures, Trauma System Regionalization Reduces Mortality and Time to Definitive Care in Severely Injured Patients.

He JC, Schechtman D, Allen DL, Cremona JJ, Claridge JA.

Am Surg. 2017 Jun 1;83(6):591-597.

PMID:
28637560
6.

Current Pneumonia Surveillance Methodology: Similar Underestimation in Trauma and Surgical Patients in the Intensive Care Unit.

Zosa BM, Golob JF, Conrad-Schnetz KJ, Schechtman D, Kreiner LA, Claridge JA.

Surg Infect (Larchmt). 2017 Jul;18(5):558-562. doi: 10.1089/sur.2016.152. Epub 2017 May 31.

PMID:
28561600
7.

FBXO25 regulates MAPK signaling pathway through inhibition of ERK1/2 phosphorylation.

Teixeira FR, Manfiolli AO, Vieira NA, Medeiros AC, Coelho PO, Santiago Guimarães D, Schechtman D, Gomes MD.

Arch Biochem Biophys. 2017 May 1;621:38-45. doi: 10.1016/j.abb.2017.04.003. Epub 2017 Apr 5.

PMID:
28389297
8.

Leaving the Skin Incision Open May Not Be as Beneficial as We Have Been Taught.

He JC, Zosa BM, Schechtman D, Brajcich B, Savakus JC, Wojahn AL, Wang DZ, Claridge JA.

Surg Infect (Larchmt). 2017 May/Jun;18(4):431-439. doi: 10.1089/sur.2017.018. Epub 2017 Mar 23.

PMID:
28332921
9.

Trauma system regionalization improves mortality in patients requiring trauma laparotomy.

Schechtman D, He JC, Zosa BM, Allen D, Claridge JA.

J Trauma Acute Care Surg. 2017 Jan;82(1):58-64. doi: 10.1097/TA.0000000000001302.

PMID:
28005711
10.

What is the fate of the cholecystostomy tube following percutaneous cholecystostomy?

Boules M, Haskins IN, Farias-Kovac M, Guerron AD, Schechtman D, Samotowka M, O'Rourke CP, McLennan G, Walsh RM, Morris-Stiff G.

Surg Endosc. 2017 Apr;31(4):1707-1712. doi: 10.1007/s00464-016-5161-x. Epub 2016 Aug 12.

PMID:
27519595
11.

Benefit of TeamSTEPPS Rounding Improvement Project on Infection-Related Monitoring.

He JC, Golob JF, Brajcich BC, Clancy K, Schechtman D, Claridge JA.

Surg Infect (Larchmt). 2016 Oct;17(5):530-4. doi: 10.1089/sur.2015.089. Epub 2016 Aug 11.

PMID:
27513027
12.

Scaffold proteins LACK and TRACK as potential drug targets in kinetoplastid parasites: Development of inhibitors.

Qvit N, Schechtman D, Pena DA, Berti DA, Soares CO, Miao Q, Liang LA, Baron LA, Teh-Poot C, Martínez-Vega P, Ramirez-Sierra MJ, Churchill E, Cunningham AD, Malkovskiy AV, Federspiel NA, Gozzo FC, Torrecilhas AC, Manso Alves MJ, Jardim A, Momar N, Dumonteil E, Mochly-Rosen D.

Int J Parasitol Drugs Drug Resist. 2016 Feb 12;6(1):74-84. doi: 10.1016/j.ijpddr.2016.02.003. eCollection 2016 Apr.

13.

Revisiting protein kinase-substrate interactions: Toward therapeutic development.

de Oliveira PS, Ferraz FA, Pena DA, Pramio DT, Morais FA, Schechtman D.

Sci Signal. 2016 Mar 22;9(420):re3. doi: 10.1126/scisignal.aad4016. Review.

PMID:
27016527
14.

Traumatic vascular injuries: who are repairing them and what are the outcomes?

He JC, Clancy K, Schechtman D, Conrad-Schnetz KJ, Claridge JA.

Am J Surg. 2016 Mar;211(3):619-25. doi: 10.1016/j.amjsurg.2015.11.011. Epub 2015 Dec 28.

PMID:
26916960
15.

Rational design and validation of an anti-protein kinase C active-state specific antibody based on conformational changes.

Pena DA, Andrade VP, Silva GÁ, Neves JI, Oliveira PS, Alves MJ, Devi LA, Schechtman D.

Sci Rep. 2016 Feb 25;6:22114. doi: 10.1038/srep22114.

16.

Human TNF-α induces differential protein phosphorylation in Schistosoma mansoni adult male worms.

Oliveira KC, Carvalho ML, Bonatto JM, Schechtman D, Verjovski-Almeida S.

Parasitol Res. 2016 Feb;115(2):817-28. doi: 10.1007/s00436-015-4812-5. Epub 2015 Nov 7.

PMID:
26547565
17.

Protein folding creates structure-based, noncontiguous consensus phosphorylation motifs recognized by kinases.

Duarte ML, Pena DA, Nunes Ferraz FA, Berti DA, Paschoal Sobreira TJ, Costa-Junior HM, Abdel Baqui MM, Disatnik MH, Xavier-Neto J, Lopes de Oliveira PS, Schechtman D.

Sci Signal. 2014 Nov 4;7(350):ra105. doi: 10.1126/scisignal.2005412.

PMID:
25372052
18.

Activation of protein kinase C delta by ψδRACK peptide promotes embryonic stem cell proliferation through ERK 1/2.

Garavello NM, Pena DA, Bonatto JM, Duarte ML, Costa-Junior HM, Schumacher RI, Forti FL, Schechtman D.

J Proteomics. 2013 Dec 6;94:497-512. doi: 10.1016/j.jprot.2013.10.021. Epub 2013 Oct 25.

PMID:
24332066
19.

Identification of εPKC targets during cardiac ischemic injury.

Budas G, Costa HM Jr, Ferreira JC, Teixeira da Silva Ferreira A, Perales J, Krieger JE, Mochly-Rosen D, Schechtman D.

Circ J. 2012;76(6):1476-85. Epub 2012 Mar 27.

20.

FERM domain interaction with myosin negatively regulates FAK in cardiomyocyte hypertrophy.

Santos AM, Schechtman D, Cardoso AC, Clemente CF, Silva JC, Fioramonte M, Pereira MB, Marin TM, Oliveira PS, Figueira AC, Oliveira SH, Torriani ÍL, Gozzo FC, Xavier Neto J, Franchini KG.

Nat Chem Biol. 2011 Nov 20;8(1):102-10. doi: 10.1038/nchembio.717.

PMID:
22101605
21.

Structural shifts of aldehyde dehydrogenase enzymes were instrumental for the early evolution of retinoid-dependent axial patterning in metazoans.

Sobreira TJ, Marlétaz F, Simões-Costa M, Schechtman D, Pereira AC, Brunet F, Sweeney S, Pani A, Aronowicz J, Lowe CJ, Davidson B, Laudet V, Bronner M, de Oliveira PS, Schubert M, Xavier-Neto J.

Proc Natl Acad Sci U S A. 2011 Jan 4;108(1):226-31. doi: 10.1073/pnas.1011223108. Epub 2010 Dec 17.

22.

Phosphoproteomics profiling suggests a role for nuclear βΙPKC in transcription processes of undifferentiated murine embryonic stem cells.

Costa-Junior HM, Garavello NM, Duarte ML, Berti DA, Glaser T, de Andrade A, Labate CA, Ferreira AT, Perales JE, Xavier-Neto J, Krieger JE, Schechtman D.

J Proteome Res. 2010 Dec 3;9(12):6191-206. doi: 10.1021/pr100355k. Epub 2010 Nov 1.

PMID:
20936827
23.

Retinoic acid and VEGF delay smooth muscle relative to endothelial differentiation to coordinate inner and outer coronary vessel wall morphogenesis.

Azambuja AP, Portillo-Sánchez V, Rodrigues MV, Omae SV, Schechtman D, Strauss BE, Costanzi-Strauss E, Krieger JE, Perez-Pomares JM, Xavier-Neto J.

Circ Res. 2010 Jul 23;107(2):204-16. doi: 10.1161/CIRCRESAHA.109.214650. Epub 2010 Jun 3.

PMID:
20522805
24.

Specific modulation of protein kinase activity via small peptides.

Costa-Junior HM, Suetsugu MJ, Krieger JE, Schechtman D.

Regul Pept. 2009 Feb 25;153(1-3):11-8. doi: 10.1016/j.regpep.2008.12.002. Epub 2008 Dec 16. Review.

PMID:
19135095
25.

Protein kinase C delta (deltaPKC)-annexin V interaction: a required step in deltaPKC translocation and function.

Kheifets V, Bright R, Inagaki K, Schechtman D, Mochly-Rosen D.

J Biol Chem. 2006 Aug 11;281(32):23218-26. Epub 2006 Jun 18.

26.

State-specific monoclonal antibodies identify an intermediate state in epsilon protein kinase C activation.

Souroujon MC, Yao L, Chen H, Endemann G, Khaner H, Geeraert V, Schechtman D, Gordon AS, Diamond I, Mochly-Rosen D.

J Biol Chem. 2004 Apr 23;279(17):17617-24. Epub 2004 Feb 3.

27.

A critical intramolecular interaction for protein kinase Cepsilon translocation.

Schechtman D, Craske ML, Kheifets V, Meyer T, Schechtman J, Mochly-Rosen D.

J Biol Chem. 2004 Apr 16;279(16):15831-40. Epub 2004 Jan 22.

28.

Overlay method for detecting protein-protein interactions.

Schechtman D, Murriel C, Bright R, Mochly-Rosen D.

Methods Mol Biol. 2003;233:351-7. No abstract available.

PMID:
12840521
29.

Glutathione S-transferase pull-down assay.

Schechtman D, Mochly-Rosen D, Ron D.

Methods Mol Biol. 2003;233:345-50. No abstract available.

PMID:
12840520
30.

Cytotoxicity of pEGFP vector is due to residues encoded by multiple cloning site.

Endemann G, Schechtman D, Mochly-Rosen D.

Anal Biochem. 2003 Feb 15;313(2):345-7. No abstract available.

PMID:
12605876
31.

Expression and immunolocalization of the 14-3-3 protein of Schistosoma mansoni.

Schechtman D, Winnen R, Tarrab-Hazdai R, Ram D, Shinder V, Grevelding CG, Kunz W, Arnon R.

Parasitology. 2001 Dec;123(Pt 6):573-82.

PMID:
11814044
32.

Isozyme-specific inhibitors and activators of protein kinase C.

Schechtman D, Mochly-Rosen D.

Methods Enzymol. 2002;345:470-89.

PMID:
11665630
33.

Adaptor proteins in protein kinase C-mediated signal transduction.

Schechtman D, Mochly-Rosen D.

Oncogene. 2001 Oct 1;20(44):6339-47. Review.

34.

Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC.

Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW 2nd, Mochly-Rosen D.

Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11114-9. Epub 2001 Sep 11.

35.

Spontaneous occurrence of an inhibitor of protein kinase C localization in a thyroid cancer cell line: role in thyroid tumorigenesis.

Mochly-Rosen D, Fagin JA, Knauf JA, Nikiforov Y, Liron T, Schechtman D.

Adv Enzyme Regul. 2001;41:87-97. No abstract available.

PMID:
11384739
36.

The 14-3-3 protein as a vaccine candidate against schistosomiasis.

Schechtman D, Tarrab-Hazdai R, Arnon R.

Parasite Immunol. 2001 Apr;23(4):213-7.

37.

Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

Ben-Yedidia T, Tarrab-Hazdai R, Schechtman D, Arnon R.

Infect Immun. 1999 Sep;67(9):4360-6.

38.

Proteosome delivery of a protective 9B-antigen against Schistosoma mansoni.

Tarrab-Hazdai R, Schechtman D, Lowell G, Pirak E, Arnon R.

Int J Immunopharmacol. 1999 Mar;21(3):205-18.

PMID:
10348370
39.

Synthesis and characterization of a protective peptide-based vaccine against Schistosoma mansoni.

Tarrab-Hazdai R, Schechtman D, Arnon R.

Infect Immun. 1998 Sep;66(9):4526-30.

40.

An association between activity of the Na/K-pump and resistance of Schistosoma mansoni towards complement-mediated killing.

Tarrab-Hazdai R, Camacho M, Mendelovic F, Schechtman D.

Parasite Immunol. 1997 Sep;19(9):395-400.

41.

Stage-specific expression of the mRNA encoding a 14-3-3 protein during the life cycle of Schistosoma mansoni.

Schechtman D, Ram D, Tarrab-Hazdai R, Arnon R, Schechter I.

Mol Biochem Parasitol. 1995 Jul;73(1-2):275-8. No abstract available.

PMID:
8577340
42.

Electrophoretic karyotype and chromosome assignments for a pathogenic and a nonpathogenic strain of Entamoeba histolytica.

Petter R, Rozenblatt S, Schechtman D, Wellems TE, Mirelman D.

Infect Immun. 1993 Aug;61(8):3574-7.

43.

Granulocyte-macrophage colony-stimulating factor increases the infectivity of Leishmania amazonensis by protecting promastigotes from heat-induced death.

Barcinski MA, Schechtman D, Quintao LG, Costa Dde A, Soares LR, Moreira ME, Charlab R.

Infect Immun. 1992 Sep;60(9):3523-7.

44.

Granulocyte-macrophage colony-stimulating factor is a growth-factor for promastigotes of Leishmania mexicana amazonensis.

Charlab R, Blaineau C, Schechtman D, Barcinski MA.

J Protozool. 1990 Sep-Oct;37(5):352-7.

PMID:
2213649

Supplemental Content

Loading ...
Support Center